Tumor necrosis factor-alpha, transforming growth factor-β1, and interleukin-10 gene polymorphisms: Implication in protection or susceptibility to dengue hemorrhagic fever

Human Immunology

Volumn 71, Issue 11, 2010, Pages 1135-1140

  Perez, Ana B ^a   Sierra, Beatriz ^a   Garcia, Gissel ^a   Aguirre, Eglis ^a   Babel, Nina ^b   Alvarez, Mayling ^a   Sanchez, Licel ^a   Valdes, Luis ^c   Volk, Hans D ^b   Guzman, Maria G ^a  

^a INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Center of Epidemiology and Hygiene   (Cuba)

Author keywords

Cytokines; Dengue hemorrhagic fever; Genetic polymorphism

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTECEDENT VARIABLE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENGUE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; INFECTION SENSITIVITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SECONDARY INFECTION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; DENGUE HEMORRHAGIC FEVER; DENGUE VIRUS; DISEASE PROGRESSION; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; SHOCK; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77957750625     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.08.004     Document Type: Article

References (60)

1. Nimmannitya S. Clinical spectrum and management of dengue haemorrhagic fever. Southeast Asian J Trop Med Public Health 1987, 18:392-397.
2. Kouri G.P., Guzman M.G., Bravo J.R. Why dengue haemorrhagic fever in Cuba?. 2. An integral analysis. Trans R Soc Trop Med Hyg 1987, 81:821-823.
3. Harris E., Holden K.L., Edgil D., Polacek C., Clyde K. Molecular biology of flaviviruses. Novartis Found Sympos 2006, 277:23-39. discussion 40, 71-3, 251-3.
4. Halstead S.B. Dengue. Lancet 2007, 370:1644-1652.
5. Alvarez M., Rodriguez-Roche R., Bernardo L., Vazquez S., Morier L., Gonzalez D., et al. Dengue hemorrhagic fever caused by sequential dengue 1-3 virus infections over a long time interval: Havana epidemic, 2001-2002. Am J Trop Med Hyg 2006, 75:1113-1117.
6. Guzman M.G., Kouri G. Dengue haemorrhagic fever integral hypothesis: Confirming observations, 1987-2007. Trans R Soc Trop Med Hyg 2008, 102:522-523.
7. Chaturvedi U.C., Nagar R., Shrivastava R. Dengue and dengue haemorrhagic fever: Implications of host genetics. FEMS Immunol Med Microbiol 2006, 47:155-166.
8. Sierra B.C., Kourí G., Guzmán M.G. Race: A risk factor for dengue hemorrhagic fever. Arch Virol 2007, 152:533-542.
9. Sierra B., Alegre R., Perez A.B., Garcia G., Sturn-Ramirez K., Obasanjo O., et al. HLA-A, -B, -C, and -DRB1 allele frequencies in Cuban individuals with antecedents of dengue 2 disease: Advantages of the Cuban population for HLA studies of dengue virus infection. Hum Immunol 2007, 68:531-540.
10. García G., Sierra B., Pérez A.B., Aguirre E., Rosado I., Gonzalez N., et al. Asymptomatic dengue infection in a Cuban population confirms the protective role of the RR variant of the FcgammaRIIa polymorphism. Am J Trop Med Hyg 2010, 82:1153-1156.
11. Rothman A.L. Cellular immunology of sequential dengue virus infection and its role in disease pathogenesis. Curr Top Microbiol Immunol 2010, 338:83-98.
12. Kurane I. Dengue hemorrhagic fever with special emphasis on immunopathogenesis. Comp Immunol Microbiol Infect Dis 2007, 30:329-340.
13. Gubler D.J. Dengue/dengue haemorrhagic fever: History and current status. Novartis Found Sympos 2006, 277:3-16. discussion 22, 71-3, 251-3.
14. Guzman M.G., Kouri G. Dengue and dengue hemorrhagic fever in the Americas: Lessons and challenges. J Clin Virol 2003, 27:1-13.
15. Mas P. Dengue Fever in Cuba in 1977: Some Laboratory Aspects. PAHO, Scientific Publishing 1979, 375:40-43.
16. Guzman M.G., Kouri G.P., Bravo J., Soler M., Vazquez S., Morier L. Dengue Hemorrhagic Fever in Cuba: A retrospective seroepidemiologic Study. Am J Trop Med Hyg 1981, 42:179-184.
17. Kouri G., Guzman M.G., Valdes L., Carbonel I., del Rosario D., Vazquez S., et al. Reemergence of dengue in Cuba: A 1997 epidemic in Santiago de Cuba. Emerg Infect Dis 1998, 4:89-92.
18. Guzman M.G., Kouri G., Valdes L., Bravo J., Alvarez M., Vazques S., et al. Epidemiologic studies on dengue in Santiago de Cuba, 1997. Am J Epidemiol 2000, 152:793-799. discussion 804.
19. Peláez O., Guzmán M.G., Kourí G., Pérez R., San Martín J.L., Vázquez S., et al. Dengue 3 epidemic, Havana, 2001. Emerg Infect Dis 2004, 10:719-722.
20. Malavige G.N., Fernando S., Fernando D.J., Seneviratne S.L. Dengue viral infections. Postgrad Med J 2004, 80:588-601.
21. Mangada M.M., Rothman A.L. Altered cytokine responses of dengue-specific;CD4+ T cells to heterologous serotypes. J Immunol 2005, 175:2676-2683.
22. Kurane I., Takasaki T. Dengue fever and dengue haemorrhagic fever: Challenges of controlling an enemy still at large. Rev Med Virol 2001, 11:301-311.
23. Agarwal R., Elbishbishi E.A., Chaturvedi U.C., Nagar R., Mustafa A.S. Profile of transforming growth factor-beta 1 in patients with dengue haemorrhagic fever. Int J Exp Pathol 1999, 80:143-149.
24. Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control 1997, World Health Organization, World Health Organization, Geneva. (edition 2).
25. Lanciotti R.S., Calisher C.H., Gubler D.J., Chang G.J., Vorndam A.V. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 1992, 30:545-551.
26. Rodriguez-Roche R., Alvarez M., Gritsun T., Rosario D., Halstead S., Kouri G., et al. Dengue virus type 2, in Cuba 1997; Conservation of E gene sequence in isolates obtained at different times during the epidemic. Arch Virol 2005, 150:415-425.
27. Vazquez S., Saenz E., Huelva G., Gonzalez A., Kouri G., Guzman M. Detection of IgM against the dengue++ virus in whole blood absorbed on filter paper. Rev Panam Salud Publ 1998, 3:174-178.
28. Vazquez S., Valdes O., Pupo M., Delgado I., Alvarez M., Pelegrino J.L., Guzman M.G. MAC-ELISA and ELISA inhibition methods for detection of antibodies after yellow fever vaccination. J Virol Methods 2003, 110:179-184.
29. Alvarez V.M., Valdes Palacios D., Vazquez Ramudo S., Delgado Hernandez I., Garcia Infante S., Morier Diaz L., et al. The standardization of the plaque reduction technic for differentiating a dengue infection from a yellow fever infection. Rev Cubana Med Trop 1998, 50:177-181.
30. Morens D.M., Halstead S.B., Repik P.M., Putvatana R., Raybourne N. Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization. J Clin Microbiol 1985, 22:250-254.
31. Ollier W.E.R. Cytokine genes and disease susceptibility. Cytokines 2004, 28:174-178.
32. Arcaroli J., Fessler M.B., Abraham E. Genetic polymorphism and sepsis. Shock 2005, 24:300-312.
33. Holegaard M.V., Bidwell J.L. Cytokines Gene polymorphism in human disease: Online database, supplement 3. Genes Immun 2006, 7:269-276.
34. Weinberg C.R., Morris R.W. Testing for Hardy-Weinberg disequilibrium using a genome single-nucleotide polymorphism scan based on cases only. Am J Epidemiol 2003, 158:401-403.
35. Alegre R., Moscoso J., Martinez-Laso J., Martin-Villa M., Suarez J., Moreno A., et al. HLA genes in Cubans and the detection of Amerindian alleles. Mol Immunol 2007, 44:2426-2435.
36. Loke H., Bethell D.B., Phuong C.X., Dung M., Schneider J., White N.J., et al. Strong HLA class I-restricted T cell responses in dengue hemorrhagic fever: A double-edged sword?. J Infect Dis 2001, 184:1369-1373.
37. Fernandez-Mestre M.T., Gendzekhadze K., Rivas-Vetencourt P., Layrisse Z. TNF-alpha-308 A allele, a possible severity risk factor of hemorrhagic manifestation in dengue fever patients. Tissue Antigens 2004, 64:469-472.
38. Vejbaesya S., Luangtrakool P., Luangtrakool K., Kalayanarooj S., Vaughn D.W., Endy T.P., et al. TNF and LTA Gene, allele, and extended HLA haplotype associations with severe dengue virus infection in ethnic Thais. J Infect Dis 2009, 199:1442-1448.
39. Chen R.F., Wanga L., Chengb J.-T., Chuanga H., Changa J.-C., Liuc J.-W., et al. Combination of CTLA-4 and TGFβ1 gene polymorphisms associated with dengue hemorrhagic fever and virus load in a dengue-2 outbreak. Clin Immunol 2009, 131:404-409.
40. Gao J., Shan G., Sun B., Thompson P.J., Gao X. Association between polymorphism of tumour necrosis factor alpha-308 gene promoter and asthma: A meta-analysis. Thorax 2006, 61:466-471.
41. Settin A., Ismail A., El-Magd M.A., El-Baz R., Kazamel A. Gene polymorphisms of TNF-alpha-308 (G/A), IL-10 (-1082) G/A), IL-6(-174) (G/C) and IL-1Ra (VNTR) in Egyptian cases with type 1 diabetes mellitus. Autoimmunity 2009, 42:50-55.
42. Babel N., Cherepnev G.Y., Kowalenko A., Horstrup J., Volk H.D., Reinke P. Nonimmunologic complications and gene polymorphisms of immunoregulatory cytokines in long-term renal transplants. Kidney Int 2004, 66:428-432.
43. Miyairi I., DeVincenzo J.P. Human genetic factors and respiratory syncytial virus disease severity. Clin Microbiol Rev 2008, 21:686-703.
44. Gao Q.J., Liu D.W., Zhang S.Y., Jia M., Wang L.M., Wu L.H., et al. Polymorphisms of some cytokines and chronic hepatitis B and C virus infection. World J Gastroenterol 2009, 15:5610-5619.
45. Oleksyk T.K., Shrestha S., Truelove A.L., Goedert J.J., Donfield S.M., Phair J., et al. Extended IL10 haplotypes and their association with HIV progression to AIDS. Genes Immun 2009, 10:309-322.
46. Chakravarti A., Kumaria R. Circulating levels of tumour necrosis factor-alpha and interferon-gamma; in patients with dengue and dengue haemorrhagic fever during an outbreak. Indian J Med Res 2006, 123:25-30.
47. Restrepo B.N., Isaza D.M., Salazar C.L., Ramírez R., Ospina M., Alvarez L.G. Serum levels of interleukin-6, tumor necrosis factor-alpha and interferon-gamma in infants with and without dengue. Rev Soc Bras Med Trop 2008, 41:6-10.
48. Cardier J.E., Marino E., Romano E., Taylor P., Liprandi F., Bosch N., Rothman A.L. Proinflammatory factors present in sera from patients with acute dengue infection induce activation and apoptosis of human microvascular endothelial cells: Possible role of TNF-alpha in endothelial cell damage in dengue. Cytokines 2005, 30:359-365.
49. Yen Y.T., Chen H.C., Lin Y.D., Shieh C.C., Wu-Hsieh B.A. Enhancement by tumor necrosis factor alpha of dengue virus-induced endothelial cell production of reactive nitrogen and oxygen species is key to hemorrhage development. J Virol 2008, 82:12312-12324.
50. Schroder K., Hertzog P.J., Ravasi T., Hume D.A. Interferon-gamma: An overview of signals, mechanisms and functions. J Leukoc Biol 2004, 75:163-189.
51. Libraty D.H., Endy T.P., Houng H.S.H., Green S., Kalayanarooj S., Suntayakorn S., et al. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect Dis 2002, 185:1213-1221.
52. Sierra B., Perez A.B., Vogt K., Garcia G., Schmolke K., Aguirre E., et al. Secondary heterologous dengue infection risk: Disequilibrium between immune regulation and inflammation?. Cell Immunol 2010, 262:134-140.
53. Mangada M.M., Endy T.P., Nisalak A., Chunsuttiwat S., Vaughn D.W., Libraty D.H., et al. Dengue-specific T cell responses in peripheral blood mononuclear cells obtained prior to secondary dengue virus infections in Thai schoolchildren. J Infect Dis 2002, 185:1697-1703.
54. Mosser D.M., Zhang X. Interleukin-10: New perspectives on an old cytokine. Immunol Rev 2008, 226:205-218.
55. Schexneider K.I., Reedy E.A. Thrombocytopenia in dengue fever. Curr Hematol Rep 2005, 4:145-148.
56. Perez A.B., Garcia G., Sierra B., Alvarez M., Vazquez S., Cabrera M.V., et al. IL-10 levels in dengue patients: Some findings from the exceptional epidemiological conditions in Cuba. J Med Virol 2004, 73:230-234.
57. Turner D.M., Williams D.M., Sankaran D., Lazarus M., Sinnott P.J., Hutchinson I.V. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997, 24:1-8.
58. Opdal S.H. IL-10 gene polymorphisms in infectious disease and sides. FEMS Immunol Med Microbiol 2004, 42:48-52.
59. Li M.O., Flavell R.A. Contextual Regulation of Inflammation: A duet by transforming growth factor-β and interleukin-10. Immunity 2008, 28:468-476.
60. Laur F., Murgue B., Deparis X., Roche C., Cassar O., Chungue E. Plasma levels of tumour necrosis factor alpha and transforming growth factor beta-1 in children with dengue 2 virus infection in French Polynesia. Trans R Soc Trop Med Hyg 1998, 92:654-656.